Who Owns Edgepark Medical Supplies?

Edgepark Medical Supplies was founded in 1930 as an independent medical supply provider. The company spent decades building a reputation for reliable delivery of medical supplies to patients' homes, focusing on chronic conditions that required ongoing product replenishment.

For most of its early history, Edgepark operated as a privately held company. Its core business involved shipping ostomy supplies, urology products, and wound care materials directly to patients, handling insurance verification and reimbursement paperwork on their behalf. This service model differentiated Edgepark from traditional medical equipment dealers who served hospitals and clinics.

In the 2000s, Edgepark became part of AssuraMed, a medical supply distributor backed by private equity. AssuraMed consolidated several direct-to-consumer medical supply brands under one corporate structure, with Edgepark as its primary consumer-facing brand. AssuraMed grew through acquisitions and organic expansion, building a national distribution network.

In 2013, Cardinal Health acquired AssuraMed for $2.7 billion. The deal was Cardinal Health's largest acquisition at the time and represented a strategic push into the direct-to-patient medical supply market. Cardinal Health integrated AssuraMed's brands, including Edgepark, into a new at-Home Solutions division. The acquisition gave Cardinal Health access to over 1 million patients and a national distribution infrastructure for home medical supplies.

Following the acquisition, Edgepark continued operating under its own brand name. Cardinal Health invested in upgrading Edgepark's digital ordering platform, expanding product categories, and improving insurance verification automation. The company expanded its diabetes product portfolio significantly, adding continuous glucose monitors (CGMs) and insulin pump supplies.

In April 2025, Cardinal Health acquired Advanced Diabetes Supply Group (ADSG) for approximately $1.1 billion. ADSG included the brands Advanced Diabetes Supply and US MED. Cardinal Health merged ADSG's operations with Edgepark under the at-Home Solutions umbrella, with Anthony Alvarez leading both businesses. The integration brought ADSG's 500,000 patients into the at-Home Solutions platform. Since the ADS acquisition, the team migrated all ADS volume onto Edgepark's distribution network, onboarded nearly 500,000 new customers, and launched ContinuCare Pathway, a pharmacy-to-supplier digital referral program.

In July 2025, Edgepark expanded its diabetes portfolio with two new products: the Dexcom Stelo Glucose Biosensor, the first FDA-cleared over-the-counter glucose biosensor, and the Eversense 365 CGM, the first FDA-cleared one-year implantable continuous glucose monitor. These additions positioned Edgepark as a supplier of both prescription and over-the-counter diabetes monitoring products.

In July 2026, Cardinal Health announced two additional acquisitions to expand at-Home Solutions: AdaptHealth's Diabetes Health business for $235 million (serving 225,000 patients annually) and Strive Medical for $125 million (serving 20,000 patients annually with urology, wound care, and ostomy supplies). These acquisitions further strengthened Edgepark's position in diabetes and urology supply categories.